Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) Requires Death Receptor Fas, in Addition to LFA-1, To Trigger Cell Death in T Lymphocytes
暂无分享,去创建一个
[1] Angela C. Brown,et al. Aggregatibacter actinomycetemcomitans Leukotoxin Is Delivered to Host Cells in an LFA-1-Indepdendent Manner When Associated with Outer Membrane Vesicles , 2018, Toxins.
[2] N. Balashova,et al. Aggregatibacter actinomycetemcomitans leukotoxin induces cytosol acidification in LFA-1 expressing immune cells. , 2016, Molecular oral microbiology.
[3] J. Bertino,et al. LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes. , 2015, Leukemia research.
[4] S. Kachlany,et al. Expression and targeting of lymphocyte function‐associated antigen 1 (LFA‐1) on white blood cells for treatment of allergic asthma , 2015, Journal of leukocyte biology.
[5] S. Kachlany,et al. Leukotoxin kills rodent WBC by targeting leukocyte function associated antigen 1. , 2013, Comparative medicine.
[6] S. Kachlany,et al. Leukotoxin (Leukothera®) Targets Active Leukocyte Function Antigen-1 (LFA-1) Protein and Triggers a Lysosomal Mediated Cell Death Pathway* , 2012, The Journal of Biological Chemistry.
[7] S. Kachlany,et al. In vitro synergism between LFA-1 targeting leukotoxin (Leukothera™) and standard chemotherapeutic agents in leukemia cells. , 2011, Leukemia research.
[8] C. Rosada,et al. Resolution of psoriasis by a leukocyte-targeting bacterial protein in a humanized mouse model. , 2011, The Journal of investigative dermatology.
[9] Michael Loran Dustin,et al. HIV Envelope gp120 Activates LFA-1 on CD4 T-Lymphocytes and Increases Cell Susceptibility to LFA-1-Targeting Leukotoxin (LtxA) , 2011, PloS one.
[10] D. Speicher,et al. Aggregatibacter actinomycetemcomitans leukotoxin is post-translationally modified by addition of either saturated or hydroxylated fatty acyl chains. , 2011, Molecular oral microbiology.
[11] A. Sjöstedt,et al. Cellular and molecular response of human macrophages exposed to Aggregatibacter actinomycetemcomitans leukotoxin , 2011, Cell Death and Disease.
[12] David A. Cheresh,et al. Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.
[13] N. Balashova,et al. Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells. , 2010, Leukemia research.
[14] S. Kachlany,et al. Aggregatibacter actinomycetemcomitans Leukotoxin , 2010, Journal of dental research.
[15] N. Balashova,et al. Aggregatibacter actinomycetemcomitans LtxC is required for leukotoxin activity and initial interaction between toxin and host cells. , 2009, Gene.
[16] D. Speicher,et al. Aggregatibacter actinomycetemcomitans leukotoxin requires β‐sheets 1 and 2 of the human CD11a β‐propeller for cytotoxicity , 2007, Cellular microbiology.
[17] N. Balashova,et al. Human CD18 Is the Functional Receptor for Aggregatibacter actinomycetemcomitans Leukotoxin , 2007, Infection and Immunity.
[18] D. Speicher,et al. Aggregatibacter actinomycetemcomitans leukotoxin requires beta-sheets 1 and 2 of the human CD11a beta-propeller for cytotoxicity. , 2007, Cellular microbiology.
[19] E. Lally,et al. Actinobacillus actinomycetemcomitans leukotoxin requires lipid microdomains for target cell cytotoxicity , 2006, Cellular microbiology.
[20] N. Balashova,et al. Characterization of leukotoxin from a clinical strain of Actinobacillus actinomycetemcomitans. , 2006, Microbial pathogenesis.
[21] T. Kinashi,et al. Intracellular signalling controlling integrin activation in lymphocytes , 2005, Nature Reviews Immunology.
[22] N. Hogg,et al. How T cells use LFA-1 to attach and migrate. , 2004, Immunology letters.
[23] R. Claesson,et al. Caspase 1 Involvement in Human Monocyte Lysis Induced by Actinobacillus actinomycetemcomitans Leukotoxin , 2003, Infection and Immunity.
[24] J. Moyano,et al. Engagement of α4β1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine , 2002, Journal of Leukocyte Biology.
[25] P. Howard,et al. Maintenance of oxidative phosphorylation protects cells from Actinobacillus actinomycetemcomitans leukotoxin‐induced apoptosis , 2001, Cellular microbiology.
[26] JS Damiano,et al. Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and γ-irradiation , 2001, Leukemia.
[27] J. Korostoff,et al. Perturbation of mitochondrial structure and function plays a central role in Actinobacillus actinomycetemcomitans leukotoxin-induced apoptosis. , 2000, Microbial pathogenesis.
[28] I. Caragol,et al. A novel CD18 genomic deletion in a patient with severe leucocyte adhesion deficiency: a possible CD2/lymphocyte function‐associated antigen‐1 functional association in humans , 2000, Immunology.
[29] S. Dirnhofer,et al. Expression of LFA-1 identifies different prognostic subgroups in patients with advanced follicle center lymphoma (FCL). , 1999, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.
[30] P. Stanley,et al. Acylation of Escherichia coli Hemolysin: A Unique Protein Lipidation Mechanism Underlying Toxin Function , 1998, Microbiology and Molecular Biology Reviews.
[31] M. Peter,et al. Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.
[32] Jian Fei Wang,et al. RTX Toxins Recognize a β2 Integrin on the Surface of Human Target Cells* , 1997, The Journal of Biological Chemistry.
[33] K. Elkon,et al. Requirement of Cysteine-rich Repeats of the Fas Receptor for Binding by the Fas Ligand* , 1997, The Journal of Biological Chemistry.
[34] Manuel C. Peitsch,et al. Characterization of Fas (Apo-1, CD95)-Fas Ligand Interaction* , 1997, The Journal of Biological Chemistry.
[35] T. Springer,et al. Characterization of lymphocyte function-associated antigen 1 (LFA-1)-deficient T cell lines: the alphaL and beta2 subunits are interdependent for cell surface expression. , 1997, Journal of immunology.
[36] P. Kiener,et al. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils , 1996, The Journal of experimental medicine.
[37] M. Peter,et al. Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor. , 1995, The EMBO journal.
[38] P. Stanley,et al. Fatty acylation of two internal lysine residues required for the toxic activity of Escherichia coli hemolysin. , 1994, Science.
[39] N. Hogg,et al. Control of leukocyte integrin activation. , 1993, The American review of respiratory disease.
[40] A. Fischer,et al. Leukocyte adhesion deficiency: molecular basis and functional consequences. , 1988, Immunodeficiency reviews.
[41] G. Inghirami,et al. Differential expression of LFA-1 molecules in non-Hodgkin's lymphoma and lymphoid leukemia. , 1988, Blood.